158 related articles for article (PubMed ID: 32665279)
1. Neurofibromatosis-associated pulmonary hypertension: an ominous duo.
Coelho SG; Loureiro MJ
BMJ Case Rep; 2020 Jul; 13(7):. PubMed ID: 32665279
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary hypertension associated with neurofibromatosis type 1.
Jutant EM; Girerd B; Jaïs X; Savale L; O'Connell C; Perros F; Sitbon O; Humbert M; Montani D
Eur Respir Rev; 2018 Sep; 27(149):. PubMed ID: 30158278
[TBL] [Abstract][Full Text] [Related]
3. Phenotype and Outcomes of Pulmonary Hypertension Associated with Neurofibromatosis Type 1.
Jutant EM; Jaïs X; Girerd B; Savale L; Ghigna MR; Perros F; Mignard X; Jevnikar M; Bourlier D; Prevot G; Tromeur C; Bauer F; Bergot E; Dauphin C; Favrolt N; Traclet J; Soumagne T; De Groote P; Chabanne C; Magro P; Bertoletti L; Gueffet JP; Chaouat A; Goupil F; Moceri P; Borie R; Fadel E; Wolkenstein P; Brillet PY; Simonneau G; Sitbon O; Humbert M; Montani D
Am J Respir Crit Care Med; 2020 Sep; 202(6):843-852. PubMed ID: 32437637
[No Abstract] [Full Text] [Related]
4. Pulmonary hypertension in patients with neurofibromatosis type I.
Montani D; Coulet F; Girerd B; Eyries M; Bergot E; Mal H; Biondi G; Dromer C; Hugues T; Marquette C; O'Connell C; O'Callaghan DS; Savale L; Jaïs X; Dorfmüller P; Begueret H; Bertoletti L; Sitbon O; Bellanné-Chantelot C; Zalcman G; Simonneau G; Humbert M; Soubrier F
Medicine (Baltimore); 2011 May; 90(3):201-211. PubMed ID: 21512413
[TBL] [Abstract][Full Text] [Related]
5. Atrial septostomy and disease targeting therapy in pulmonary hypertension secondary to neurofibromatosis.
Giannakoulas G; Savvoulidis P; Grosomanidis V; Mouratoglou SA; Karvounis H; Hadjimiltiades S
BMC Pulm Med; 2016 Dec; 16(1):175. PubMed ID: 27927206
[TBL] [Abstract][Full Text] [Related]
6. Type 1 neurofibromatosis complicated by pulmonary arterial hypertension: A case report.
Küçük M; Öncel CR; Uçar M; Yıldırım AB
Turk Kardiyol Dern Ars; 2017 Jul; 45(5):458-461. PubMed ID: 28694401
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary hypertension: a fatal complication of neurofibromatosis type 1.
Gumbiene L; Petrulioniene Z; Rucinskas K; Maneikiene V; Serpytis P; Dranenkiene A; Laucevicius A
Respir Care; 2011 Nov; 56(11):1844-8. PubMed ID: 21605478
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary hypertension and von Recklinghausen's disease: association and therapeutic difficulties.
Ennibi K; El Kassimi I; Asfalou I; Chaari J; Benyass A
Pneumologia; 2015; 64(3):55-7. PubMed ID: 26738373
[TBL] [Abstract][Full Text] [Related]
9. Is pulmonary arterial hypertension in neurofibromatosis type 1 secondary to a plexogenic arteriopathy?
Stewart DR; Cogan JD; Kramer MR; Miller WT; Christiansen LE; Pauciulo MW; Messiaen LM; Tu GS; Thompson WH; Pyeritz RE; Ryu JH; Nichols WC; Kodama M; Meyrick BO; Ross DJ
Chest; 2007 Sep; 132(3):798-808. PubMed ID: 17573495
[TBL] [Abstract][Full Text] [Related]
10. Type 1 neurofibromatosis complicated by pulmonary artery hypertension: a case report.
Simeoni S; Puccetti A; Chilosi M; Tinazzi E; Prati D; Corrocher R; Lunardi C
J Med Invest; 2007 Aug; 54(3-4):354-8. PubMed ID: 17878687
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary hypertension secondary to interstitial lung disease.
Shlobin OA; Nathan SD
Expert Rev Respir Med; 2011 Apr; 5(2):179-89. PubMed ID: 21510729
[TBL] [Abstract][Full Text] [Related]
12. Favorable effect of sorafenib in a patient with neurofibromatosis-associated pulmonary hypertension.
Tamura Y; Ono T; Sano M; Fukuda K; Kataoka M; Satoh T
Am J Respir Crit Care Med; 2012 Aug; 186(3):291-2. PubMed ID: 22855545
[No Abstract] [Full Text] [Related]
13. Pulmonary hypertension associated with sickle cell disease: pathophysiology and rationale for treatment.
Benza RL
Lung; 2008; 186(4):247-254. PubMed ID: 18470553
[TBL] [Abstract][Full Text] [Related]
14. Management of Pulmonary Hypertension: Associated with Left Heart Disease.
Franco V
Heart Fail Clin; 2018 Oct; 14(4):545-551. PubMed ID: 30266363
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary hypertension in neurofibromatosis.
Engel PJ; Baughman RP; Menon SG; Kereiakes DJ; Taylor L; Scott M
Am J Cardiol; 2007 Apr; 99(8):1177-8. PubMed ID: 17437753
[TBL] [Abstract][Full Text] [Related]
16. Macitentan Use in a Neurofibromatosis Type 1 Patient With Pulmonary Hypertension and External Jugular Phlebectasia.
Correale M; Tarantino N; Paradiso G; Monaco I; Di Biase M; Brunetti ND
Am J Ther; 2018; 25(5):e587-e590. PubMed ID: 29059078
[No Abstract] [Full Text] [Related]
17. Long-term outcome in a patient with pulmonary hypertension and hereditary hemorrhagic telangiectasia.
Minai OA; Rigelsky C; Eng C; Arroliga AC; Stoller JK
Chest; 2007 Apr; 131(4):984-7. PubMed ID: 17426199
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary Hypertension in Patients With COPD: Results From the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA).
Vizza CD; Hoeper MM; Huscher D; Pittrow D; Benjamin N; Olsson KM; Ghofrani HA; Held M; Klose H; Lange T; Rosenkranz S; Dumitrescu D; Badagliacca R; Claussen M; Halank M; Vonk-Noordegraaf A; Skowasch D; Ewert R; Gibbs JSR; Delcroix M; Skride A; Coghlan G; Ulrich S; Opitz C; Kaemmerer H; Distler O; Grünig E
Chest; 2021 Aug; 160(2):678-689. PubMed ID: 33581097
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary Arterial Hypertension-Specific Drug Therapy in COPD Patients with Severe Pulmonary Hypertension and Mild-to-Moderate Airflow Limitation.
Calcaianu G; Canuet M; Schuller A; Enache I; Chaouat A; Kessler R
Respiration; 2016; 91(1):9-17. PubMed ID: 26492415
[TBL] [Abstract][Full Text] [Related]
20. Medical Management of Pulmonary Hypertension with Unclear and/or Multifactorial Mechanisms (Group 5): Is There a Role for Pulmonary Arterial Hypertension Medications?
Weatherald J; Savale L; Humbert M
Curr Hypertens Rep; 2017 Oct; 19(11):86. PubMed ID: 29046979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
